The Charcot-Marie-Tooth Association (CMTA) is transforming the future of CMT research, CMT treatments, and CMT...
CMTA’s New Video Aims to Increase Awareness About CMT
Charcot-Marie-Tooth disease (CMT) is the most common inheritable peripheral neuropathy, affecting millions of people worldwide....
CMTA Announces New Center of Excellence at Virginia Commonwealth University
CMTA has designated a new Center of Excellence at Virginia Commonwealth University, expanding access to specialty care for people living with CMT in Virginia and the surrounding region.
CMT vs. Muscular Dystrophy: Key Differences That Set Them Apart
CMT and muscular dystrophy can both cause muscle weakness, but they have different underlying causes and affect the body in different ways. Knowing these differences is essential for accurate diagnosis and care.
CMT is Not an Autoimmune Disease: Exploring the Key Differences
CMT and autoimmune diseases can share similar symptoms, but they have very different causes, progression patterns, and treatment approaches. Knowing these differences is critical for accurate diagnosis and care.
CMTA Updates List of Neurotoxic Meds Potentially More Hazardous to CMT Patients
CMTA has updated its Neurotoxic Drug List following a comprehensive scientific review of medications known or suspected to affect peripheral nerves. The review found that, with two specific anticancer drugs, most medications pose no greater risk to people with CMT than to the general population, helping patients and clinicians make informed treatment decisions.
CMTA Kicks Off CMT Awareness Month 2022
CMTA kicks off CMT Awareness Month 2022 with a month-long series of educational and community-driven activities designed to increase understanding of CMT. The campaign highlights people living with CMT and encourages public participation through digital engagement and awareness efforts.
Alan Jackson shares his CMT story with the Today Show
This morning, country star Alan Jackson shared his journey with Charcot-Marie-Tooth disease on the Today...
